In another study of NSCLC patients treated with anti-PD-1 antibodies, TCR clonotype analysis was performed on matched biopsy samples of skin and tumor from 4 patients who developed dermatologic IRAEs [36]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.